Pantaleoni Pablo
Known title: Chief Digital OfficerCIK: 0001864258
Associated companies
Transaction History
| LFST | ▼ Sell | Tax Withholding | 12,622 | $90K | 3/10/2025 | View on chart |
| LFST | ▼ Sell | Tax Withholding | 9,650 | $64K | 3/10/2025 | View on chart |
| LFST | ▼ Sell | Open Market | 15,605 | $119K | 3/10/2025 | View on chart |
| LFST | ▼ Sell | Tax Withholding | 14,607 | $111K | 3/7/2025 | View on chart |
| LFST | ▼ Sell | Tax Withholding | 28,947 | $220K | 3/7/2025 | View on chart |
| LFST | ▲ Buy | Grant | 42,765 | $0 | 3/7/2025 | View on chart |
| LFST | ▼ Sell | Open Market | 19,900 | $145K | 3/7/2025 | View on chart |
| LFST | ▲ Buy | Grant | 98,578 | $0 | 3/7/2025 | View on chart |
| LFST | ▼ Sell | Tax Withholding | 19,444 | $153K | 3/6/2025 | View on chart |
| LFST | ▲ Buy | Grant | 117,386 | $0 | 3/6/2025 | View on chart |
| LFST | ▼ Sell | Open Market | 10,116 | $60K | 4/1/2024 | View on chart |
| LFST | ▼ Sell | Open Market | 43,304 | $293K | 3/12/2024 | View on chart |
| LFST | ▲ Buy | Grant | 128,294 | $0 | 3/8/2024 | View on chart |
| LFST | ▲ Buy | Grant | 98,579 | $0 | 3/8/2024 | View on chart |
| LFST | ▼ Sell | Open Market | 6,435 | $49K | 4/4/2023 | View on chart |
| LFST | ▲ Buy | Grant | 197,649 | $0 | 3/6/2023 | View on chart |
| LFST | ▲ Buy | Grant | 98,084 | $0 | 4/25/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Keybanc Raises LifeStance Health Price Target to $15
Keybanc maintained an Overweight rating on LifeStance Health and raised its price target to $15. This follows the company's recent Q2 2026 earnings call. The stock is currently trading near the middle of its 52-week range, with an average analyst target of $14.40.
Keybanc Raises LifeStance Health Price Target to $15. Keybanc maintained an Overweight rating on LifeStance Health and raised its price target to $15. This follows the company's recent Q2 2026 earnings call. The stock is currently trading near the middle of its 52-week range, with an average analyst target of $14.40.